CA
NZ
UK
AU
IND
US
A pre-fundedWarrantlets an investor pay almost the full price up front and exercise later for a nominal sum, which helps holders who want to stay under an ownership threshold. Both instruments add to the share count, so existing holders own a smaller slice. Simple …
CAVA restaurant-level profit was USD 82.7 million, up 16.2%, but the margin fell to 23.4% on added labor investment, more third-party delivery and higher repairs and maintenance. Management notes delivery dilutes the margin rate while adding margin dollars because of higher guest prices. Net …
GAAP results were thin.Net Incomewas USD 3.4 million, andGAAPEPS from continuing operations was USD 0.02. Adjusted EPS of USD 0.88 strips out items such as amortization, integration costs related to the LimaAcquisitionand separation costs, so investors should weigh both. Cash and equivalents fell to …
The U.S.-based precious metals producer runs seven North American operations: New Afton, Rainy River, Las Chispas, Palmarejo, Rochester, Kensington and Wharf. It produced 161,400 ounces of gold and 4.2 million ounces of silver in the quarter, with silver down 12% year over year on …
Backlog rose USD 148.4 million since year end. Orders for vehicle blast attenuation seats, blast exposure monitoring sensors and remotely operated vehicles added USD 93.4 million, the current-year acquisition USD 39.7 million and nuclear safety products USD 10.6 million. Duty gear holsters across channels …
Adjusted EBITDA was USD 83.4 million, up 46%, and the margin widened to 42% from 34%, showingOperating Leverageas extra revenue costs little to process. For the fourth quarter Magnite guided contribution ex-TAC of USD 227 million to USD 233 million. For 2026 it now …
Last-twelve-month cash from operations was USD 3.1 billion and freeCash FlowUSD 2.0 billion, a 53% conversion of adjusted EBITDA, or 61% excluding USD 306 million of deposits to Canada tied to a United States and CanadaTransfer Pricingmatter. Management notes those deposits will be applied …
GAAP net income was USD 85 million versus USD 18 million, while adjusted net income was USD 90 million versus USD 56 million. The year-ago quarter is distorted by the commercial partnership with a medical lab automation channel partner, so excluding it adjusted EPS …
Net cash fromOperating Activitieswas USD 781.4 million, adjusted EBITDA (non-GAAP) was USD 871.3 million and adjusted freeCash Flowwas USD 431.5 million, or USD 442 million excluding reimbursableCapitalspending. The release text pairs USD 871.3 million with operating cash flow, but the tables show it as …
Key HighlightsXeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% after third quarterRevenueclimbed 44% to USD 107.2 million and the 2030 revenue outlook was lifted above USD 1 billion.Vericel Corporation (NASDAQ:VCEL) gained 20.27% after revenue grew 26% to USD 85.4 million and full-year guidance was raised …
Please wait processing your request...